Decartes-08

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Investigating an mRNA CAR T-cell Therapy, Known as Descartes-08, as a Potential Approach to Treat Myasthenia GravisNCT06799247Cartesian TherapeuticsPhase 3Active not recruiting2026-12-30Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.